{"data":{"id":"us-sd/sdcl-58-17h-56","jurisdiction":"us-sd","citation":"SDCL § 58-17H-56","heading":"Limitations.","body":"Nothing in §§ 58-17H-53 to 55-17H-56 shall be construed to prevent:\n(1)A health carrier, health benefit plan, or utilization review organization from requiring a covered person to try a prescription drug with the same generic name and demonstrated bioavailability or biological product that is an interchangeable biological product pursuant to §§ 36-11-46.1 and 36-11-46.9 before providing coverage for the equivalent branded prescription drug;\n(2)A health care professional from prescribing a prescription drug that is determined to be medically appropriate.","path":["TITLE 58. INSURANCE","CHAPTER 58-17H. UTILIZATION REVIEW AND BENEFIT DETERMINATIONS"],"source_url":"https://sdlegislature.gov/Statutes/58-17H-56","current_through":"2026-08-31","vintage":"","retrieved_at":"2026-09-03T15:18:57Z","sha256":"c33b0d1293ce07ccb2ad4b811333fabd1aa4ef1a8050cc089ff57fba9bbe45b3","source_id":"us-sd","stale":true,"prev":"us-sd/sdcl-58-17h-55","next":"us-sd/sdcl-58-17h-57"},"notice":"GroundRules: Original legal text. Not legal advice."}